Vimarsana
Biggest News Aggregation in the World

Page 3 - Reproductive Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reproductive Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reproductive Sciences Today - Breaking & Trending Today

UCSF: Mailing Abortion Pills- Timely and Effective Delivery - Vimarsana News

UCSF: Mailing Abortion Pills- Timely and Effective Delivery

Dispensing abortion pills through the mail works as well as requiring patients to get them in person from a clinic or doctor’s office, according to new research from UC San Francisco, which comes as the Supreme Court is considering whether to disallo

Infertility treatment linked to higher postpartum heart disease risk - Vimarsana News

Infertility treatment linked to higher postpartum heart disease risk

A study by Rutgers Health experts of more than 31 million hospital records shows that infertility treatment patients were twice as likely as those who conceived naturally to be hospitalized with heart disease in the year after delivery.

Dr Hartwich on Preclinical Findings for Y3 Plus Chemotherapy in Ovarian Cancer - Vimarsana News

Dr Hartwich on Preclinical Findings for Y3 Plus Chemotherapy in Ovarian Cancer

Yang Yang Hartwich, PhD discusses a study delving into the mechanisms underlying chemoresistance in ovarian cancer.

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer - Vimarsana News

Dr Eskander on Pembrolizumab Plus Chemo in Advanced/Recurrent Endometrial Cancer

Ramez N. Eskander, MD, discusses overall survival data for pembrolizumab plus chemotherapy in advanced/recurrent endometrial cancer.

Study: New Research Finds Steroids Safe and Effective for Late Preterm Infants - Vimarsana News

Study: New Research Finds Steroids Safe and Effective for Late Preterm Infants

New research finds that infants of pregnant individuals exposed to antenatal betamethasone at 34 to 36 weeks of gestation show no adverse neurodevelopmental out